Leveraging Local LLMs for Multi-Omics Data Interpretation

Multi-omics analysis doesn’t have a data problem — it has an interpretation problem.

Modern experiments generate enormous volumes of results, but integrating them into a coherent biological narrative remains slow, manual, and dependent on individual expertise. What if you could use LLMs as a structured analytical layer in your multi-omics pipeline?

We’ve been exploring exactly that, and the results are promising — with important caveats.

The Interpretation Bottleneck

A single spatial transcriptomics study might produce:

Hundreds of differentially expressed genes across multiple comparisons
Dozens of enriched pathways from GSEA or ORA
Cell type deconvolution estimates across multiple compartments
RNA-protein concordance metrics for dozens of markers

Each of these analyses generates interpretable outputs. But integrating them — asking “what does this all mean together?” — remains a manual, time-consuming process that depends heavily on individual expertise.

This is where LLMs can add value: not as a replacement for domain expertise, but as a structured synthesis layer that identifies patterns across analysis modalities.

Our Approach: Multi-Model Consensus

Rather than relying on a single LLM (with all its biases and hallucination risks), we developed a consensus pipeline that queries multiple independent models and identifies findings agreed upon by the majority.

Pipeline Architecture

Data Preparation: Key statistical results from each analysis modality are compressed into a structured ~7KB representation — including summarized DEG lists, pathway enrichments, cell-type proportions, and concordance metrics in a format optimized for model input
Model Ensemble: Five independent LLMs process the same structured input, each generating integration analyses, draft abstracts, and clinical interpretation
Consensus Extraction: Findings are retained only if agreed upon by 3 or more of the 5 models. This majority threshold balances sensitivity (capturing real signals) with robustness (filtering model-specific artifacts)
Human Review: All consensus findings are reviewed by domain experts before inclusion in any manuscript or report

Why Multiple Models?

Single-model outputs suffer from well-documented issues (Ji et al., 2023):

Hallucination: An LLM might confidently assert a biological relationship that doesn’t exist in your data
Bias: Each model has training data biases that can skew interpretation
Inconsistency: The same model may produce different interpretations on repeated runs

By requiring consensus across architecturally different models, we filter out model-specific artifacts while retaining findings that multiple independent “perspectives” agree on. Using models with different training data and architectures reduces correlated errors — if three fundamentally different models reach the same conclusion, it’s more likely to reflect something real in your data.

Why Local?

We run all models locally using frameworks like Ollama. This is critical for several reasons:

Data privacy: Research data never leaves the local environment. No patient data, unpublished findings, or proprietary analyses are sent to cloud APIs.
Reproducibility: Local deployment with fixed model versions and low temperature settings (we use 0.3) produces more consistent results.
Cost: After initial hardware investment, there are no per-query costs — important when running dozens of structured queries per project.

What Works Well

Cross-Modality Pattern Recognition

LLMs excel at identifying patterns that span analysis types. For example, when presented with:

Deconvolution showing increased macrophage infiltration in a specific tissue region
Differential expression showing upregulated inflammatory pathways in the same region
Protein data confirming elevated checkpoint expression

An LLM can synthesize these into a coherent narrative about immune activation in that compartment. In one dataset, three models independently linked macrophage infiltration with checkpoint pathway activation in the tumor compartment — a connection that was present in the data but not immediately apparent from any single analysis modality. A human expert would reach the same conclusion, but the LLM does it in seconds rather than hours.

Draft Abstract Generation

Given structured results, LLMs produce surprisingly good first-draft abstracts that capture the key findings and frame them in appropriate clinical context. These always require expert editing, but they provide a useful starting scaffold.

Identifying Non-Obvious Connections

Occasionally, the consensus pipeline surfaces connections that weren’t immediately apparent — for instance, linking a pathway enrichment finding to a known drug target or clinical trial, drawing on the model’s training data in ways that complement traditional literature review.

What Doesn’t Work (Yet)

Statistical Reasoning

LLMs are unreliable at evaluating statistical evidence. They may overinterpret marginally significant findings (p = 0.04) or dismiss highly significant results that contradict their “expectations.” All statistical conclusions must come from the actual analysis, not the LLM.

Novelty Assessment

LLMs cannot reliably distinguish between a well-known finding and a genuinely novel one. Their training data captures the published literature, so they tend to frame everything as consistent with existing knowledge — even when your data might challenge it.

Quantitative Accuracy

Never trust an LLM to accurately report effect sizes, sample sizes, or p-values from your data. Even when the correct numbers are in the input, models sometimes introduce subtle errors in their outputs. Always cross-reference quantitative claims against the source data.

In short: LLMs are strong at pattern synthesis, but weak at quantitative reasoning and statistical judgment.

Practical Recommendations

If you’re considering incorporating LLMs into your analysis pipeline:

Use them for synthesis, not analysis. LLMs should operate on results, not raw data. Run your differential expression, pathway enrichment, and deconvolution first, then feed the results to the LLM.
Require consensus. A single model’s output is an opinion. Consensus across multiple models is a more reliable signal.
Keep data local. Especially for unpublished research or data with any patient-adjacent information, use locally deployed models.
Set low temperature. For analytical tasks, high creativity (temperature) is counterproductive. We use 0.3 for structured analysis queries.
Always validate. LLM outputs are drafts, not conclusions. Every finding should be traceable to your actual data.
Remember: garbage in, garbage out. The quality of LLM output is entirely dependent on the quality and structure of the input data. Poorly summarized or biased inputs will produce misleading interpretations, regardless of model quality.

The Bigger Picture

LLMs won’t replace bioinformaticians or domain scientists (Lin et al., 2025). But they can meaningfully accelerate the interpretation bottleneck in multi-omics research — the step between “we have results” and “we understand what they mean.”

This isn’t experimental — we’re actively using these pipelines in real multi-omics projects at Cytogence. The goal isn’t automation for its own sake — it’s faster time to insight, with the same rigor that good science demands.

References

Ji Z, Lee N, Frieske R, et al. Survey of hallucination in natural language generation. ACM Computing Surveys. 2023;55(12):Article 248. doi: 10.1145/3571730.
Lin A, Ye J, Qi C, et al. Bridging artificial intelligence and biological sciences: a comprehensive review of large language models in bioinformatics. Briefings in Bioinformatics. 2025;26(4):bbaf357. doi: 10.1093/bib/bbaf357.

Cytogence combines deep bioinformatics expertise with cutting-edge computational approaches. Contact us to learn how we can accelerate your research.